Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

David Gimenez

Surgery Winston Salem, NC Medical Doctor

NPI 1114989100 CMS profile 1192193

3333 Silas Creek Pkwy, Winston Salem, NC 27103

Open in the dashboard

General payments

$7,778

29 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, David Gimenez of Winston Salem, NC is reported in the CMS Open Payments database as having received $7,778 across 29 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $7,348 14
2022 General $145 3
2021 General $25 2
2020 General $63 2
2019 General $197 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Gimenez
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to David Gimenez were reported at $0. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year David Gimenez Surgery median Middle half National median
2019 $197 $253 $82–$1,521 $163
2020 $63 $131 $40–$706 $114
2021 $25 $168 $50–$904 $132
2022 $145 $224 $76–$1,218 $149
2023 $7,348 $253 $82–$1,255 $160
2024 $0 $279 $90–$1,381 $164
2025 $0 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Intuitive Surgical, Inc. $7,480 16 payments
  2. CONMED Corporation $71 1 payment
  3. Avanir Pharmaceuticals, Inc. $66 3 payments
  4. AstraZeneca Pharmaceuticals LP $29 1 payment
  5. AngioDynamics, Inc. $28 1 payment
  6. Neurelis, Inc. $19 1 payment
  7. Flexion Therapeutics, Inc. $16 1 payment
  8. Janssen Pharmaceuticals, Inc $15 1 payment
  9. Otsuka America Pharmaceutical, Inc. $15 1 payment
  10. Xeris Pharmaceuticals, Inc. $14 1 payment
  11. Other $25 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Education $5,500 2 payments
  2. Travel and Lodging $1,665 6 payments
  3. Food and Beverage $614 21 payments
Products named General payments · program years 2019–2023
  1. DAVINCI XI $5,500 2 payments
  2. Da Vinci Surgical System $1,980 14 payments
  3. AirSeal $71 1 payment
  4. NUEDEXTA $66 3 payments
  5. FASENRA $29 1 payment
  6. VALTOCO $19 1 payment
  7. Zilretta $16 1 payment
  8. XARELTO $15 1 payment
  9. INVOKANA $15 1 payment
  10. ABILIFY MAINTENA $15 1 payment
  11. Other $25 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$37,510

Medicare's payments for the services billed

Medicare patients

135

Average age 73

Services billed

260

67 women, 68 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Chronic kidney disease 46%
Ischemic heart disease 43%
Depression 42%
Diabetes 37%
Heart failure 36%
Atrial fibrillation 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

29 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record